Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing
Journal of Clinical Medicine · 26.01.2025 · 14 (3) · 804
DOI: 10.3390/jcm14030804 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.01.2025. Verfasst von Elizabeth S Tarras und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, CT 06511, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pulmonary arterial hypertension (PAH) is a rare, progressive disease of the pulmonary vasculature that is associated with pulmonary vascular remodeling and right heart failure. While there have been recent advances both in understanding pathobiology and in diagnosis and therapeutic options, PAH remains a disease with significant delays in diagnosis and high morbidity and mortality. Information from invasive cardiopulmonary exercise testing (iCPET) presents an important opportunity to evaluate the dynamic interactions within and between the right heart circulatory system and the skeletal muscle during different loading conditions to enhance early diagnosis, phenotype disease subtypes, and personalize treatment in PAH given the shortcomings of contemporary diagnostic and therapeutic approaches. The purpose of this review is to present the current applications of iCPET in PAH and to discuss future applications of the testing methodology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, CT 06511, USA.
ORCID-Profile: Inderjit Singh, Phillip Joseph
Zitieren
APA
Tarras, E. S., Singh, I., Kreiger, J., & Joseph, P. (2025). Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing. Journal of Clinical Medicine, 14(3), 804. https://doi.org/10.3390/jcm14030804
Vancouver
Tarras ES, Singh I, Kreiger J, Joseph P. Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing. Journal of Clinical Medicine. 2025;14(3):804. doi:10.3390/jcm14030804
BibTeX
@article{Tarras2025,
author = {Tarras, Elizabeth S and Singh, Inderjit and Kreiger, Joan and Joseph, Phillip},
title = {Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {3},
pages = {804},
doi = {10.3390/jcm14030804}
}
EUVIMED